TD Ameritrade Investment Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-30
| Closed | -$7K | – | 632 |
|
|
2021
Q3 | $7K | Buy |
30
+7
| +30% | +$1.63K | ﹤0.01% | 481 |
|
|
2021
Q2 | $9K | Sell |
23
-7
| -23% | -$2.74K | ﹤0.01% | 472 |
|
|
2021
Q1 | $7K | Hold |
30
| – | – | ﹤0.01% | 503 |
|
|
2020
Q4 | $7K | Hold |
30
| – | – | ﹤0.01% | 503 |
|
|
2020
Q3 | $7K | Sell |
30
-10
| -25% | -$2.33K | ﹤0.01% | 481 |
|
|
2020
Q2 | $7K | Sell |
40
-41
| -51% | -$7.18K | ﹤0.01% | 466 |
|
|
2020
Q1 | $10K | Buy |
81
+11
| +16% | +$1.36K | ﹤0.01% | 411 |
|
|
2019
Q4 | $11K | Sell |
70
-2
| -3% | -$314 | ﹤0.01% | 441 |
|
|
2019
Q3 | $10K | Buy |
72
+1
| +1% | +$139 | ﹤0.01% | 426 |
|
|
2019
Q2 | $10K | Sell |
71
-4
| -5% | -$563 | ﹤0.01% | 389 |
|
|
2019
Q1 | $11K | Sell |
75
-77
| -51% | -$11.3K | ﹤0.01% | 333 |
|
|
2018
Q4 | $17K | Hold |
152
| – | – | ﹤0.01% | 311 |
|
|
2018
Q3 | $20K | Buy |
+152
| New | +$20K | ﹤0.01% | 281 |
|